Purchase Order 75N94021P00563

Award Date 7/20/21
Potential Completion Date 9/13/21
Potential Value $89K
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sleepy Hollow, NY 10591, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $70,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Siemens Healthcare Diagnostics Inc. for the provision of a PERFORMANCE PLAN PLUS FOR DIMENSION EXL 200 diagnostic system. The contract has a performance period ending on February 29, 2028. The award is not set-aside and is structured as a firm fixed price purchase order. Siemens Healthcare Diagnostics Inc. is a subsidiary of Siemens Aktiengesellschaft...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer of medical testing equipment, reagents, and supplies. The contract has a ceiling value of $8,602.00 and a completion date of September 21, 2009. It is not associated with any set-aside program. This award is a standalone contract and not part of a larger contracting vehicle....
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to Siemens Healthcare Diagnostics Inc. The $11,000 contract is for NIDDK fee applications support, which likely includes the provision of diagnostic equipment, reagents, consumables, and associated services to support clinical laboratory testing operations at NIDDK medical facilities. Siemens...
The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $50,058 firm fixed price purchase order to Siemens Healthcare Diagnostics Inc. to procure a BN II ROHS system. The system will support nephelometry testing performed by the National Institute of Diabetes and Digestive and Kidney Disease Phoenix Epidemiology and Clinical Research Branch in furtherance of several studies and research projects. As the...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is a civilian agency, to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer of medical testing equipment, reagents, and supplies. The contract, valued at $24,814.54, is a firm-fixed-price purchase order for undisclosed products or services with a performance period ending on September 30, 2009. The contract did not have a set-aside designation. Siemens...
This federal contract award, valued at $75,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft. The award is for the purchase of an ADVIA 2120 diagnostic instrument, including a conversion kit, on a firm fixed-price basis. There was no set-aside used for this contract. Siemens Healthcare Diagnostics Inc. is a manufacturer of in vitro diagnostic...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer of medical testing equipment, reagents, and supplies. The $18,295.20 firm fixed-price purchase order was awarded on September 18, 2007 with no set-aside designation. The contract supports the NIDDK's clinical laboratory testing needs, leveraging Siemens Healthcare Diagnostics Inc.'s...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Siemens Healthcare Diagnostics Inc. The contract is for the provision of a Siemens hematology analyzer and is valued at $111,250.00. The contract has a period of performance through February 28, 2017 and does not utilize any set-aside designations. Siemens Healthcare Diagnostics Inc. is a subsidiary of the larger Siemens...
This is a firm fixed-price delivery order contract awarded by the Navy Bureau of Medicine and Surgery (BUMED) to Siemens Healthcare Diagnostics Inc. for a DIMENSION EXL-LM CHEMISTRY ANALYZER. The contract has a ceiling value of $96,000.00 and a completion date of March 31, 2020. It was awarded on April 1, 2019 under the GSA Schedule for Critical Analyzers, Laboratory (FSS-66-III). This contract does not have a set-aside designation. Siemens Healthcare Diagnostics Inc. is a subsidiary of...
This is a firm fixed-price delivery order awarded by the Defense Health Agency to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, for the supply of SIEMENS EXL200 CHEMISTRY ANALYZER COST PER TEST. The order is placed against Siemens' GSA Schedule contract for Critical Analyzers, Laboratory (FSS-66-III) and has a ceiling value of $63,145.77. Siemens Healthcare Diagnostics Inc. is a global provider of in vitro diagnostic solutions and laboratory services to various...

This is a $88,766.25 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to Siemens Healthcare Diagnostics Inc. to procure a Dimension EXL 200 Chemistry Analyzer. Siemens Healthcare Diagnostics Inc. is a subsidiary of the global technology conglomerate Siemens Aktiengesellschaft. The contract was awarded on a sole-source basis without full and open competition under simplified acquisition procedures, as Siemens Healthcare Diagnostics is the sole manufacturer and provider of the Dimension EXL 200 Analyzer. The award does not utilize any set-aside programs. This purchase supports the clinical and research testing operations at the NIDDK laboratory facility located in Phoenix, Arizona.

Generated 4/2/25, 4:17 PM